Smoking Cessation for Persons Living With HIV: A Review of Currently Available Interventions
Smoking among persons living with HIV infection (PLWH) is estimated to be two to three times greater than the general population. Data suggest that cigarette smoking is more common among PLWH because of factors such as lower socioeconomic status, previous or concurrent illicit drug and alcohol use, age, education level, and concurrent depressive symptoms. Cigarette smoking in HIV-infected individuals has been associated with higher risk of certain cancers, infections, and a decrease in response to antiretroviral therapy. Recent guidelines from the U.S. Public Health Service have recommended the use of counseling and pharmacologic therapies for all patients interested in quitting smoking. It is critical for clinicians caring for PLWH to be familiar with these modalities. This article provides an overview of currently available interventions for smoking cessation, reviews considerations for patients with HIV, and discusses clinical implications for nurses and advanced practice clinicians.
Available from: Shin-Woo Kim
- "disease progression. In general, anxiety and depression are known to be related with cigarette smoking or alcohol drinking (Boschloo et al., 2013; Khaled, Bulloch, Exner, & Patten, 2009; Kimbrel, Morissette, Gulliver, Langdon, & Zvolensky, 2014) and cigarette smoking is more common among HIV-infected individuals because of depressive symptoms (Jeffrey & Kathryn, 2010). As a result of it, quality of life can be adversely affected (Lim & Kim, 2013) and the duration of survival will be decreased (Ickovics et al., 2001). "
[Show abstract] [Hide abstract]
ABSTRACT: Patients infected with human immunodeficiency virus (HIV) may develop mental health problems such as anxiety and depression, which negatively impact of disease progression. We investigated factors associated with the prevalence of anxiety and depression symptoms among HIV-infected patients in Korea. A total of 840 HIV-infected patients who participated in the Korea HIV/AIDS Cohort Study from 2006 to 2012 were evaluated. Socio-demographic, epidemiologic, and clinical variables were obtained through standardized questionnaires. The State-Trait Anxiety Inventory and Beck Depression Inventory were used to assess the symptoms of anxiety and depression. Multiple logistic regression analyses were performed to identify factors associated with symptoms of anxiety and depression. The prevalence of anxiety and depressive symptoms among HIV-infected patients was 32% and 36%, respectively. Ex-smoker and persistent symptoms for more than one week within the past six months and diagnosis of HIV infection within one year were associated with increased anxiety symptoms (odds ratio [OR] 1.71, 95% confidence interval [CI] 1.09-2.69; OR 1.52, 95% CI 1.09-2.11; OR 1.49, 95% CI 1.02-2.20) and current smoking and persistent symptoms were also associated with increased depressive symptoms (OR 2.10, 95% CI 1.31-3.30; OR 1.87, 95% CI 1.25-2.79). Marital status, current smoking, current drinking, and persistent symptoms were associated with both increased anxiety and depressive symptoms (OR 1.75, 95% CI 1.07-2.88; OR 1.66, 95% CI 1.06-2.61; OR 1.88, 95% CI 1.18-2.99). The prevalence of anxiety and depressive symptoms among HIV-infected patients is higher than those estimated for the general population. This study shows the necessity to evaluate symptoms of anxiety and depression and suggest psychological support for HIV-infected patients who smoke or have persistent symptoms or have sexual partner or drink.
AIDS Care 07/2015; 27(9):1-9. DOI:10.1080/09540121.2015.1035861 · 1.60 Impact Factor
Available from: Rifat Atun
- "Another Cochrane review showed that mobile phone based smoking cessation interventions have a positive effective in the short-term (the trial we included  was excluded in the Cochrane review because of short follow-up ), which is consistent with our findings. Smoking has additional health risks for PLHIV and increasing the effectiveness of cessation interventions is very important for improving the health of this group , , . "
[Show abstract] [Hide abstract]
ABSTRACT: Low cost, effective interventions are needed to deal with the major global burden of HIV/AIDS. Telephone consultation offers the potential to improve health of people living with HIV/AIDS cost-effectively and to reduce the burden on affected people and health systems. The aim of this systematic review was to assess the effectiveness of telephone consultation for HIV/AIDS care.
We undertook a comprehensive search of peer-reviewed and grey literature. Two authors independently screened citations, extracted data and assessed the quality of randomized controlled trials which compared telephone interventions with control groups for HIV/AIDS care. Telephone interventions were voice calls with landlines or mobile phones. We present a narrative overview of the results as the obtained trials were highly heterogeneous in design and therefore the data could not be pooled for statistical analysis.
The search yielded 3321 citations. Of these, nine studies involving 1162 participants met the inclusion criteria. The telephone was used for giving HIV test results (one trial) and for delivering behavioural interventions aimed at improving mental health (four trials), reducing sexual transmission risk (one trial), improving medication adherence (two trials) and smoking cessation (one trial). Limited effectiveness of the intervention was found in the trial giving HIV test results, in one trial supporting medication adherence and in one trial for smoking cessation by telephone.
We found some evidence of the benefits of interventions delivered by telephone for the health of people living with HIV or at risk of HIV. However, only limited conclusions can be drawn as we only found nine studies for five different interventions and they mainly took place in the United States. Nevertheless, given the high penetration of low-cost mobile phones in countries with high HIV endemicity, more evidence is needed on how telephone consultation can aid in the delivery of HIV prevention, treatment and care.
PLoS ONE 05/2012; 7(5):e36105. DOI:10.1371/journal.pone.0036105 · 3.23 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: One new way to cost-effectively distribute educational materials is through the use of CD-ROM supplements. The authors proposed that the creation of a CD-ROM in biomaterials would be useful to two target audiences. One audience includes clinicians who can benefit from a second, more scientific approach to clinical uses of biomaterials. The second group includes scientists and engineers who are involved in device development yet may not have a strong understanding of the clinical environment. This manuscript outlines the authors' approach in creating the CD-ROM. The metrics to analyse the effectiveness of the CD-ROM are not complete
Biomedical Engineering Conference, 1997., Proceedings of the 1997 Sixteenth Southern; 05/1997
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.